Study finds COVID-19 convalescent plasma therapy safe, with 76 percent patients improving

The first convalescent plasma transfusion trial results from Houston Methodist have been released. Of the study’s 25 patients, 19 have improved and 11 have been discharged. With no adverse side effects caused by the therapy, the study concluded convalescent plasma is a safe treatment option for patients with severe COVID-19. This is the largest cohort assessed for outcomes related to convalescent plasma therapy for COVID-19 and the first peer-reviewed publication of it in the US.